Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0NN4U
|
|||
| Drug Name |
PMID26924192-Compound-105
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
MEDIVATION TECHNOLOGIES, INC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H17NO3
|
|||
| Canonical SMILES |
CN(C1=CC(=CC(=C1)C(C2=CC=CC=C2)O)O)C(=O)C=C
|
|||
| InChI |
1S/C17H17NO3/c1-3-16(20)18(2)14-9-13(10-15(19)11-14)17(21)12-7-5-4-6-8-12/h3-11,17,19,21H,1H2,2H3/t17-/m0/s1
|
|||
| InChIKey |
ISTAOAGDLRWZMS-KRWDZBQOSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bromodomain testis-specific protein (BRDT) | Target Info | Inhibitor | [1] |
| Bromodomain-containing protein 2 (BRD2) | Target Info | Inhibitor | [1] | |
| Bromodomain-containing protein 3 (BRD3) | Target Info | Inhibitor | [1] | |
| Bromodomain-containing protein 4 (BRD4) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Bromodomain testis-specific protein (BRDT) | Target's Patent Info | [1] | |
| Bromodomain-containing protein 2 (BRD2) | Target's Patent Info | [1] | ||
| Bromodomain-containing protein 3 (BRD3) | Target's Patent Info | [1] | ||
| Bromodomain-containing protein 4 (BRD4) | Target's Patent Info | [1] | ||
| NetPath Pathway | IL2 Signaling Pathway | |||
| TGF_beta_Receptor Signaling Pathway | ||||
| Pathway Interaction Database | Regulation of retinoblastoma protein | |||
| WikiPathways | Chemical Compounds to monitor Proteins | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.